Top

Published in:

01-05-2003 | Correspondence

Comment on "Terlipressin in chronic hyperdynamic endotoxic shock: is it safe?" by P. Asfar

Authors: Bart L. De Keulenaer, Dianne P. Stephens

Published in: Intensive Care Medicine | Issue 5/2003

Excerpt

We have read with great interest the editorial about the use of terlipressin in chronic hyperdynamic endotoxic shock by Dr Asfar [1]. In our opinion, the use of vasopressin or terlipressin can be very useful in the treatment of vasodilatory shock due to their strong vasoconstrictive effects via V1a receptors. Moreover, Landry et al. [2] reported a relative vasopressin deficiency in patients with septic shock. …

Asfar P (2003) Terlipressin in chronic hyperdynamic endotoxic shock: is it safe? Intensive Care Med 29:154–155CrossRef

Landry DW, Levin HR, Gallant HM, Ashton RC, Seo S, D'Alessandro D, Oz M, Oliver JA (1997) Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95:1122–1125CrossRef

Heyndrickx GR, Boettcher DH, Vatner SF (1976) Effects of angiotensin, vasopressin and methoxamine on cardiac function and blood flow distribution in conscious dogs. Am J Physiol 231:1579–1587CrossRef

Brackett DJ, Schaefer CF, Tompkins P, Fragraeus L, Peters LJ, Wilson MF (1985) Evaluation of cardiac output, total peripheral resistance and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia. Circ Shock 17:273–284PubMed

Laszlo F, Karacsony G, Pavo I, Varga C, Rojik I, Laszlo FA (1994) Aggressive role of vasopressin in development of different gastric lesions in rats. Eur J Pharmacol 258:15–22CrossRef

O'Brien A, Clapp L, Singer M (2002) Terlipressin for norepinephrine-resistant septic shock. Lancet 359:1209–1210CrossRef

Tsuneyoshi I, Yamada H, Kakihana Y (2001) Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 29:487CrossRef

Eyraud D, Brabant S, Nathalie D (1999) Treatment of intraoperative refractory hypotension with terlipressin in patients chronically treated with an antagonist of the renin-angiotensin system. Anaest Analg 8:980–984CrossRef

Rittig S, Arentsen J, Sorensen K (1991) The hemodynamic effects of triglycyl-lysin-vasopressin (Glypressin) in patients with Parkinsonism and orthostatic hypotension. Mov Disord 6:21–28CrossRef

Title: Comment on "Terlipressin in chronic hyperdynamic endotoxic shock: is it safe?" by P. Asfar
Authors: Bart L. De Keulenaer
Dianne P. Stephens
Publication date: 01-05-2003
Publisher: Springer Berlin Heidelberg
Published in: Intensive Care Medicine / Issue 5/2003
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-003-1695-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Comment on "Terlipressin in chronic hyperdynamic endotoxic shock: is it safe?" by P. Asfar

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2003

Generalisability of randomised controlled trials: a matter of discussion

Detrimental effects of short-term mechanical ventilation on diaphragm function and IGF-I mRNA in rats

A universal method for determining intensive care unit bed requirements

Does immunonutrition in patients with sepsis do more harm than good?

Distribution of lung ventilation in spontaneously breathing neonates lying in different body positions

Triaging patients to the ICU: a pilot study of factors influencing admission decisions and patient outcomes